Literature DB >> 31583614

Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".

Katherine Langdon1, Lisa Copeland2, Priya Edwards2, Kate Rodwell2, Kim McLennan2, Theresa Carroll2, Sasaka Bandaranayake2, Adam Scheinberg3,4, Mary-Clare Waugh5, Heather Burnett6, Neil Wimalasundera7, Sabine Hennel8, Eewei Lim9, Steve O'Flaherty10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31583614     DOI： 10.1007/s40272-019-00358-2

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  15 in total

1.  Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy.

Authors:  Stephen J O'Flaherty; Vyshnavi Janakan; Angela M Morrow; Adam M Scheinberg; Mary-Clare A Waugh
Journal:  Dev Med Child Neurol       Date:  2011-02       Impact factor: 5.449

2.  Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy.

Authors:  Priya Edwards; Leanne Sakzewski; Lisa Copeland; Laura Gascoigne-Pees; Kim McLennan; Megan Thorley; Megan Kentish; Robert Ware; Roslyn N Boyd
Journal:  Pediatrics       Date:  2015-10-19       Impact factor: 7.124

3.  The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study.

Authors:  Lee Barber; Tandy Hastings-Ison; Richard Baker; H Kerr Graham; Rod Barrett; Glen Lichtwark
Journal:  J Child Orthop       Date:  2013-06-18       Impact factor: 1.548

4.  Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.

Authors:  Lisa Copeland; Priya Edwards; Megan Thorley; Samantha Donaghey; Laura Gascoigne-Pees; Megan Kentish; Grad Cert; Jayne Lindsley; Kim McLennan; Leanne Sakzewski; Roslyn N Boyd
Journal:  J Pediatr       Date:  2014-03-12       Impact factor: 4.406

5.  Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.

Authors:  Caroline Alexander; Catherine Elliott; Jane Valentine; Katherine Stannage; Natasha Bear; Cyril J Donnelly; Peter Shipman; Siobhan Reid
Journal:  Dev Med Child Neurol       Date:  2018-08-27       Impact factor: 5.449

6.  Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat?

Authors:  Jane Valentine; Sue-Anne Davidson; Natasha Bear; Eve Blair; Roslyn Ward; Ashleigh Thornton; Katherine Stannage; Linda Watson; David Forbes; Catherine Elliott
Journal:  Disabil Rehabil       Date:  2019-08-15       Impact factor: 3.033

Review 7.  A systematic review of interventions for children with cerebral palsy: state of the evidence.

Authors:  Iona Novak; Sarah McIntyre; Catherine Morgan; Lanie Campbell; Leigha Dark; Natalie Morton; Elise Stumbles; Salli-Ann Wilson; Shona Goldsmith
Journal:  Dev Med Child Neurol       Date:  2013-08-21       Impact factor: 5.449

8.  Botulinum neurotoxin A: an unusual systemic effect.

Authors:  Katherine Howell; Paulo Selber; H Kerr Graham; Dinah Reddihough
Journal:  J Paediatr Child Health       Date:  2007-06       Impact factor: 1.954

Review 9.  Botulinum Toxin in the Management of Children with Cerebral Palsy.

Authors:  Iqbal Multani; Jamil Manji; Tandy Hastings-Ison; Abhay Khot; Kerr Graham
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.022

10.  Predicting respiratory hospital admissions in young people with cerebral palsy.

Authors:  Amanda Marie Blackmore; Natasha Bear; Eve Blair; Katherine Langdon; Lisa Moshovis; Kellie Steer; Andrew C Wilson
Journal:  Arch Dis Child       Date:  2018-03-19       Impact factor: 3.791
View more
  2 in total

1.  Authors' Reply to K. Langdon and Colleagues' Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".

Authors:  Iqbal Multani; Jamil Manji; Tandy Hastings-Ison; Abhay Khot; Kerr Graham
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

2.  Protocol for The Toxin Study: Understanding clinical and patient reported response of children and young people with cerebral palsy to intramuscular lower limb Botulinum neurotoxin-A injections, exploring all domains of the ICF. A pragmatic longitudinal observational study using a prospective one-group repeated measures design.

Authors:  Lesley R Katchburian; Kate Oulton; Eleanor Main; Christopher Morris; Lucinda J Carr
Journal:  BMJ Open       Date:  2021-04-21       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.